Problems in statistical analysis of attrition in randomized controlled clinical trials of antidepressant for geriatric depression

Current Psychiatry Reviews

Volumn 3, Issue 3, 2007, Pages 178-185

  Heo, Moonseong ^a   Leon, Andrew C ^a   Meyers, Barnett S ^a   Alexopoulos, George S ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

ANOVA; Hamilton Rating Scale of Depression; Intent to treat sample; Last observation carried forward method; Montgomery Asberg Depression Rating Scale

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DOSULEPIN; DOXEPIN; FLUOXETINE; FLUPENTIXOL; FLUVOXAMINE; IMIPRAMINE; LOFEPRAMINE; MAPROTILINE; MIANSERIN; MILNACIPRAN; MINAPRINE; MIRTAZAPINE; MOCLOBEMIDE; NOMIFENSINE; NORTRIPTYLINE; PAROXETINE; PLACEBO; REBOXETINE; ROLIPRAM; SERTRALINE; TENILOXAZINE; TRAZODONE; TRIMIPRAMINE; UNINDEXED DRUG; VILOXAZINE;

ANALYSIS OF VARIANCE; CHI SQUARE TEST; CLINICAL RESEARCH; CLINICAL TRIAL; COCHRANE LIBRARY; CONTROLLED STUDY; DATA ANALYSIS; DEPRESSION; GERONTOPSYCHIATRY; HEALTH STATISTICS; HUMAN; MEDLINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; STATISTICAL ANALYSIS; STUDENT T TEST;

EID: 34548336388     PISSN: 15734005     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340007781369694     Document Type: Review

References (119)

1. Rubin DB. Inference and missing data. Biometrika 1976; 63: 581-592.
2. Leon AC, Mallinckrodt CH, Chuan-Stein C, Archibald DG, Archer GE, Chartier K. Attrition in randomized controlled clinical trials: methodological issues in psychopharmacology. Biol Psychiatry 2006; 59: 1001-1005.
3. Mottram P, Wilson K, Strobl J. Antidepressants for depressed elderly. Cochrane Database Syst Rev 2006; 25: CD003491.
4. Moizeszowicz J, Subira S. Controlled trial of nomifensin (HOE 984) and viloxazine in the treatment of depression in the elderly. J Clin Pharmacol 1977; 1: 81-3.
5. Goldstein SE, Birnbom F, Laliberte R. Nomifensine in the treatment of depressed geriatric patients. J Clin Psychiatry 1982; 43: 287-9.
6. Gentil P, De Maria F, De Vanna M, Drago F, Omer LMO, Ismail S. Disclofensine in the treatment of depressed geriatric hospitalized patients: A placebo-controlled double-blind study. Curr Therap Res 1984; 35: 386-95.
7. 3 and aslavital in the elderly. Romanian J Geront Geriatrics 1986; 7: 79-88.
8. Mulsant BH, Sweet RA, Rosen J, et al. A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life. J Clin Psychitry 200; 62: 597-604.
9. Altamura AC, Mauri MC, Colacurcio F, et al. Trazodone in late life depressive states: a double-blind multicenter study versus amitriptyline and mianserin. Psychopharmacology 1988; 95: S34-S36.
10. Mulsant BH, Pollock BG, Nebes RD, et al. A double-blind randomized comparison of nortriptyline and paroxetine in the treatment of late-life depression: 6-week outcome. J Clin Psychiatry 1999: 60[suppl 20]: 16-20.
11. Altamura AC, Mauri MC, Rudas N, et al. Clinical activity and tolerability of trazodone, mianserin, and amitriptyline in elderly subjects with major depression: A controlled mulitcenter trial. Clin Neuropharmacology 1989; Suppl. 1: S25-S33.
12. Mulsant BH, Pollock BG, Nebes R, et al. A twelve-week, double-blind, randomized comparison of nortriptyline and paroxetine in older depressed inpatients and outpatients. Am J Geriatr Psychiatry 2001; 9: 406-14.
13. Murphy Jr. GM, Hollander SB, Rodrigues HE, Kremer C, Schatzberg AF. Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression. Arch Gen Psychiatry 2004; 61: 1163-9.
14. Murphy Jr. GM, Kremer C, Rodrigues H, Schatzberg, and the mirtazapine vs, paroxetine study group. The Apolipoprotein E ε4 allele and antidepressant efficacy in cognitively intact elderly depressed patients. Biol Psychiatry 2003; 54: 665-73.
15. Rocca P, Calvarese P, Faggiano F, et al. Citalopram versus sertraline in late-life nonmajor clinically significant depression: a 1-year follow-up clinical trial. J Clin Psychiatry 2005; 66: 360-9.
16. Brodie NH, McGhie RL, O'Hara H, Valle-Jones JC. Schiff AA. Anxiety depression in elderly patients: A double-blind comparative study of fluphenazine nortriptyline and promazine. Practitioner 1975; 215: 660-4.
17. Nugent D. A double-blind study of viloxazine (vivalan) and amitriptyline in depressed geriatric patients. Clin Trials J 1979; 16: 13-7.
18. Gerner R, Estabrook W, Steuer J, Jarvik L. Treatment of geriatric depression with trazodone, imipramine, and Placebo: A double-blind study. J Clin Psychiatry 1996; 41: 216-20.
19. Goldstein SE, Birnbom F, Laliberte R. Nomifensine in the treatment of depressed geriatric patients. J Clin Psychiatry 1982; 43: 287-9.
20. Branconnier RJ, Cole JO, Ghazvinian S, Spera KF, Oxenkrug GF, Bass JL. Clinical pharmacology of bupropion and imipramine in elderly depressives. J Clin Psychiatry 1983; 44: 130-33.
21. Gwirtsman HE, Ahles S, Halaris A, DeMet E, Hill MA. Therapeutic superiority of maprotiline versus doxepin in geriatric depression. J Clin Psychiatry 1983; 44: 449-53.
22. Cohn JB, Vagra L, Lyoford A. A two-center study of nomifensine, imipramine, and placebo in depressed geriatric outpatients. J Clin Psychiatry 1984; 45:68-72.
23. Ather SA, Ankier SI, Middleton RSW. A double-blind evaluation of trazodone in the treatment of depression in the eklerly. Br J Clin Practice 1985; 6: 192-99. [Randomization is not specified - need to check again].
24. Feighner JP, Cohn JB. Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder. J Clin Psychiatry 1985; 46: 20-25.
25. Georgotas A, McCue RE, Hapworth W, et al. Comparative efficacy and safety of MAOIs versus TCAs in treating depression in the elderly. Biol Psychiatry 1986; 21: 1155-66.
26. Lakshmanan M, Mion LC, Frengley JD. Effective low dose tricyclic antidepressant treatment for depressed geriatric rehabilitation patients. JAGS 1986; 34: 421-426.
27. Siegfried K, O'Connolly M. Cognitive and psychomotor effects of different antidepressants in the treatment of old age depression. Int Clin Psychopharamcol 1986: 1; 231-43.
28. Wakelin JS. Fluvoxamine in the treatment of the older depressed patient; Double-blind, placebo-controlled data. Int Clin Psychopharamcol 1986: 1; 221-230.
29. Waite J, Grundy E, Arie T. A controlled trial of antidepressant medication in elderly in-patients. Int Clin Psychopharamcol 1986: 1; 113-126.
30. Fairbairn AF, Geroge K, Dorman T. Lofepramine versus dothiepin in the treatment of depression in the elderly patients. Br J Clin Practice 1989; 43: 55-60.
31. Falk WE, Rosenbaum JF, Otto MW, Zusky PM, Weilburg JB, Nixon RA. Fluoxetine versus trazodone in depressed geriatric patients. J Geriatric Psychiatry Neurol 1989; 2: 208-14.
32. Guillibert E, Pelicier Y, Archambault JC, et al. A double-blind, mulitcenter strudu of paroxetine versus clomiparmine in depressed elderly patients. Acta Psychiatr Scand 1989; 80 (suppl. 35); 132-4.
33. Hostmaelingen HJ, Asskilt O, Austad SG, et al. Primary care treatment of depression in the elderly: a double-blind, multi-center study of flupenthixol ('Fluanxol') and sustained-release amittriptyline. Curr Med Res Opin 1989; 11; 593-8.
34. Reifler BV, Teri L, Raskind, et al. Double-blind trial of imipramine in Alzheimer's disease patients with and without depression. Am J Psychiatry 1989; 146; 45-49.
35. Cohn CK, Shrivastava R, Mendels J, et al. Double-blind, mulitcenter comparison of sertraline and amitriptyline in elderly depressed patients. J Clin Psychiatry 1990; 51 (suppl B): 28-33.
36. Feighner JP, Boyer WF, Hendrickson GG, Pambakian RA, Doroski VS A controlled trial of adinazolam versus desipramine in geriatric depression. Int Clin Psychopharamcol 1990; 5: 227-32.
37. Katz IR, Simpson GM, Curlik SM, Parmelee PA, Muhly C. Pharmacologic treatment of major depression for elderly patients in residential care settings. J Clin Psychiatry 1990; 51 (suppl. 7): 41-7.
38. Schiafano F, Garbin A, Renesto V, et al. A double-blind comparison of mianserin and maprotiline in depressed medically ill elderly people. Acta Psychiatr Scand 1990; 81: 289-94.
39. Cohn J, Claghorn J, Ostrow D. A comparative trial of trimipramine and doxepin in depressed elderly patients. Adv Ther 1991; 2: 92-102.
40. Phanjoo AL, Wonnacott S, Hodgson A. Double-blind comparative mulitcenter study of fluvoxamine and mianserin in the treatment of major depressive episode in elderly people. Acta Psychiatr Scand 1991; 83: 476-9.
41. Rahman MK, Akhtar MJ, Savla NC, Sharma RR, Kellett JM, Ashford JJ. A Double-blind, randomized comparison of fluvoxamine with dothiepin in the treatment of depression in elderly patients. BJCP 1991; 45: 255-8.
42. Behnke K, Mejer-Nielsen, Korner A, et al. Rolipram versus nortriptyline in gerontopsychiatric in-patients with major depression. Nord J Psychiatry 1992; 46: 407-11.
43. Dorman T. Sleep and paroxetine: A comparison with mianserin in elderly depressed patients. Int Clin Psychopharamcol 1992; 6 (Suppl. 4); 53-8.
44. Dunner DL, Cohn JB, Walshe T, et al. Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression. J Clin Psychiatry 1992; 53 (2. Suppl.): 57-60.
45. Hutchinson DR, Tong S, Moon CAL, Vince M, Glarke A. Paroxetine in the treatment of elderly depressed patients in general practice A double-blind comparison with amitriptyline. Int Clin Pschopharmacol 1992; 6 (suppl. 4): 43-51.
46. La Pia S, Giorgio D, Ciriello R, et al. Evaluation of the efficacy, tolerability, and therapeutic profile of fluoxetine versus mianserin in the treatment of depressive disorders in the elderly. Curr Therapeutic Res 199; 52: 847-58.
47. Nyth AL, Gottfrie CG, Lyby K, et al. A controlled mulitcenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia. Acta Psychiatr Scand 1992; 86: 13845.
48. Weissma MM, Prusoff B, Sholomskas AJ, Greenwald S. A double-blind clinical trial of alprazolam, imipramine, or placebo in the depressed elderly. J Clin Psychopharmacol 1992; 12: 175-82.
49. Boksberger JP, Gachoud JP, Richard J, Dick P. Comparison of the efficacy and fluvoxamine in elderly patients with a severe depressive episode. Eur Psychiatr 1993; 8: 319-24.
50. Fairweather DB, Kerr JS, Harrison DA, Moon CA. A double blind comparison of the effects of fluoxetine and amitriptyline on cognitive function in elderly depressed patients. Hum Psychopharmacol 1993; 8: 41-7.
51. Nair NPV, Amin MD, Schwartz G, et al. A comparison of the cardiac safety and therapeutic efficacy of trimipramine versus doxepin in geriatric depressed patients. J Am Geriatr Soc 1993; 41: 863-7.
52. Schone W, Ludwig M. A double-blind study of paroxetine compared with fluoxetine in geriatric patients with major depression. J Clin Psychopharmacol 1993; 13(Suppl 2): 34S-39S.
53. Casacchia M, Bolino F, Marola W, et al. Controlled multicenter study of teniloxazine in mild depression of the elderly. New Trends Exp Clin Psychiatry 1994; 10: 187-92.
54. Lauritzen L, Bjerg Bendsen B, Vilma T, Bjerg Bendsen E, Lunde M, Bech P. Post-stroke depression: combined treatment with imipramine or desipremine and mianserin-a controlled clinical study. Psychopharamcology 1994; 114: 119-22.
55. Pancheri P, Delle Chiaie R, Donnini M, et al. Effects of moclobemide on depressive symptoms and cognitive performance in a geriatric population: a controlled comparative study versus imipramine. Clin Neuropharamcol 1994; 17[Suppl 1]: S58-S73.
56. Geretsegger C, Stuppaeck CH, Mair K Platz T, Fartacek R, Haim M. Multicenter double blind study of paroxetine and amitriptyline in elderly depressed inpatients. Psychopharmaoology 1995; 199: 277-81.
57. Halikas JA. Org 3770 (mitrazapine) versus trazodone: a placebo controlled trial in depressed elderly patients. Hum Psychopharmacol 1995; 10: S125-S133.
58. Nair NPV, Amin M, Holm P, et al. Moclobemide and nortiptyline in elderly depressed patients: a randomized, mulitcenter trial against placebo. J Affect Disord 1995; 33: 1-9.
59. Tollefson GD, Bosomworth JC, Heiligenstein JH, Potvin JH, Holman S, and the fluoxetine collaborative study group. A doubleblind, placebo-controlled clinical trial of fluoxetine in geriatric patients with major depression. Int Psychogeriatr 1995; 7: 89-104.
60. Hoyberg OJ, Maragakis B, Mullin J, et al. A double-blind multicenter comparison of mirtazapine and amitriptyline in elderly depressed patients. Acta Psychiatr Scand 1996; 93: 184-90.
61. Makapatra SN, Hackett D. A randomized, double-blind, parallel-group comparison of venlafaxine and dothiepin in geriatric patients with major depression. Int J Clin Pract 1997; 51: 209-13.
62. Taragano FE, Lyketsos CG, Mangone CA, Allegri RF, Comesana-Diaz E. A double-blind, randomized, fixed-dose trial of fluoxetine vs amitriptyline in the treatment of major depression complicating Alzheimer's disease/Pschosomatics 1997; 38: 246-52.
63. De Ronchi D, Rucci P, Lodi M, Ravaglia G, Forti P, Volterra V. Fluoxetine and amitriptyline in elderly depressed patients: a 10-week, double-blind study of course of neuorcognitive adverse events and depressive symptoms. Arch Gerontol Geriatr 1998: Suppl 6: 125-40.
64. Kyle CJ, Petersen HEH, Overo KF. Comparison of the tolerability and efficacy of citalopram and amitriptyline in elderly depresses patients treated in general practice. Depress Anxiety 1998; 8: 147-53.
65. Schweizer E, Rickels K, Hassman H, Garci-Espana F. Buspirone and imipramine for the treatment of major depression the elderly. J Clin Psychiatry 1998; 59: 175-83.
66. Smeraldi E, Rizzo F, Crespi G. Double0blindm randomized study of venlafaxine, clomipramine and trazodone in geriatric patients with major depression. Primary Care Psychiatry 1998; 4: 189-195.
67. Tignol J, Pujol-Domenech J, Chartres JP, et al. Double-blind study of the efficacy and safety of milnacipran and imipramine in elderly patients with major depressive episode. Acta Psychiatr Scand 1998; 97: 157-65.
68. Katona C, Bercoff E, Chiu E, Tack P, Versiani M, Woelk H. Reboxetine versus imipramine in the treatment of elderly patients with depressive disorders: a double-blind randomized trial. J Affec Disord 1999; 55: 203-13.
69. Finkel SI, Richter EM, Clary CM, Batzar E. Comparative efficacy of sertraline vs fluoxetine in patients age 70 or over with major depression. Am J Geriatr Psychiatry 1999; 7: 221-7.
70. Bondareff W, Alpert M, Friedhoff AJ, Richtere EM, Calry CM, Batzar E. Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life. Am J Psychiatry 2000; 157: 729-36.
71. Mamo DC, SweetRA, Mulsant BH, et al. Effect of nortriptyline and paroxetine on extrapyramidal signs and symptoms. Am J Geriatri Psychiatry 2000; 8: 226-31.
72. Newhouse PA, Krishnan RR, Doraiswamy PM, Richter EM, Batzar ED, Clary CM. A double-blind comparison of sertraline and fluoxetines in depressed elderly outpatients. J Clin Psychiatry 2000; 61: 559-68.
73. Weihs KL, Settle EC, Batey SR, Houser TL, Donahue RMJ, Ascher JA. Bupropin sustained release versus paroxetine for the treatment of depressive in the elderly. J Clin Psychiatry 2000; 61: 196-202.
74. Navarro V, Gasto C, Torres X, Marcos T, Pintor L, Citalopram versus nortriptyline in late-life depression: a 12-week randomized single-blind study. Acta Psychiatr Scand 2001; 103: 435-40.
75. Pollock BG, Mulsant BH, Rosen J, et al. Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients. Am J Psychiatry 2002; 159: 460-5.
76. Schatzberg AF, Kremer C, Rodrigues HE, Murphy Jr. GM, and the mirtazapine vs, paroxetine study group. Am J Geriatr Psychiatry 2002; 10: 541-50.
77. Lyketsos CG, DelCampo L, Steinberg M, et al. Treating depression in Alzheimer disease. Arch Gen Psychiatry 2003; 60: 737-46.
78. Rapaport MH, Schneider LS, Dunner DL, Davies JT, Pitts CD. Efficacy of controlled-release paroxetine in the treatment of late-life depression. J Clin Psychiatry 2003; 64: 1065-74.
79. Schneider LS, Nelson JC, Clary CM, Newhouse P, Krishnan KRR, Shiovitz T, Weihs K, and sertraline elderly depression study group. Am J Psychiatry 2003; 160: 1277-85.
80. Roose SP, Sackeim HA, Krishnan KRR, et al. Old-old depression study group. Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial. Am J Psychiatry 2004; 161: 2050-9.
81. Schatzberg A, Roose S. A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression. Am J psychiatry 2006; 14: 361-70.
82. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
83. Guy W: ECDEU Assessment Manual for Psychopharmacology - Revised (DHEW Publ No ADM 76-338). Rockville, MD, U.S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs, 1976, pp 218-222.
84. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiat 1979; 134: 382-389.
85. Lachin JM. Statistical Considerations in the intent-to-treat principle. Controll Clin Trials 2000; 21: 167-189.
86. Scheffé H. The Analysis of Variance, New York: John Wiley & Sons, Inc. 1959.
87. Student. The probable error ofa mean. Biometrika 1908; 5: 1-25.
88. Wilcoxon F. Individual comparisons by ranking methods. Biometrics 1945; 1: 80-83.
89. Mann HB, Whitney DR. On a test of whether one of two random variables is stochastically larger than the other. Ann Math Stat 1947; 18: 50-60.
90. Kruskal WH, Wallis WA. Use of ranks in one criterion variance analysis. J Am Stat Assoc 1952; 57: 583-621.
91. Neter J, Kutner MH, Wasserman W, Nachtsheim CJ. Applied Linear Statistical Models. 4th ed., New York: McGraw-Hill/Irwin, 1996.
92. 2 test of goodness of fit. Biometrika 1922; 14: 186-191
93. Fisher RA. Statistical Methods for Research Workers. Edinbergh: Oliver and Boyd, 1934.
94. Agresti A. Categorical Data Analysis. New York: John Wiley & Sons, 1990.
95. 2 tests. Biometrics 1954; 10: 417-451.
96. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Nat Cancer Inst. 1959; 22: 719-748.
97. Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd Ed., New York: John Wiley & Sons, 2000.
98. Liang K-Y, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73: 13-22.
99. Hedeker D, Gibbons RD. MIXREG: a computer program for mixed-effects regression analysis with autocorrelated errors. Comput Methods Programs Biomed 1996; 49, 229-252.
100. Verbeke G, Molenberghs G. Linear Mixed Models in Practice: a SAS-oriented approach. New York: Springer, 1997.
101. Hedeker D, Gibbons RD. A random-effects ordinal regression model for multilevel analysis. Biometrics 1994; 50:933-944
102. Hedeker D, Gibbons RD. MIXOR: a computer program for mixed-effects ordinal regression analysis. Comput Methods Prog Biomed 1996;49: 157-176.
103. Cohen J. The statistical power of abnormal-social psychological research: a review. J Abnorm Soc Psychol 1962: 65; 145-153.
104. Pinson L, Gray GE. Number needed to treat: an underused measure of treatment effect. Psychopharmacology 2003; 54: 145-154.
105. Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 1996; 276: 637-9.
106. Moher D, Schulz KF, Altman D for the CONSROT group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001; 285: 1987-1991.
107. Little RJA, Rubin DB. Statistical Analysis with Missing Data. 2n ed., New York: John Wiley & Sons, 2002.
108. Mallinckrodt CH, Watkin JG, Molenberghs G, Carroll RJ. Choice of the primary analysis in longitudinal clinical trials. Pharm Stat 2004; 3: 161-179.
109. Diggle PJ, Heagerty P, Liang K-Y, Zeger SL. Analysis of Longitudinal Data, 2nd ed., New York: Oxford University Press, 2002.
110. Krzanowski WJ. Principles of Multivariate Analysis: a user's perspective. New York: Oxford University Press, 1988.
111. American Statistical Association. Ethical Guidelines for Statistical Practice from the American Statistical Association, 1999 (available at the ASA web-site www.amstat.org/profession).
112. Lavori PW. Clinical trials in psychiatry: should protocol deviation censor patient data? Neuropsychopharamcology 1992; 6: 39-48.
113. Little RJA. Modeling dropout mechanism in longitudinal studies. J Am Stat Assoc 1995; 90: 1112-1121.
114. Mazumdar S, Tang G, Houck PR, et al. Statistical analysis of longitudinal psychiatry data with dropouts. J Psychiatr Res in press.
115. Little RJA. Pattern-mixture models for multivariate incomplete data. J Am Stat Assoc 1993; 88: 125-134.
116. Hedeker D, Gibbons RD. Application of random-effects pattern-mixture models for missing data in longitudinal studies. Psychol Methods 1997; 2, 64-78.
117. Diggle P, Kenward MG. Informative drop-out in longitudinal data analysis. Appl Stat 1994; 43: 49-93.
118. Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York: John Wiley & Sons, 1987.
119. Schafer JL. Analysis of Incomplete Multivariate Data. London: Chapman & Hall, 1997.